We are live on ! Find out more
SGAR

iPath Pure Beta Sugar ETN
SGAR

Delisted

SGAR was delisted on the 11th of April, 2018.

Back to rankings

1 hedge funds and large institutions have $28K invested in iPath Pure Beta Sugar ETN in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

211% more capital invested

Capital invested by funds: $9K → $28K (+$19K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
U
UBS
Switzerland
+$17.8K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
U
1
UBS
Switzerland
$28K +$17.8K +503 +200%

SGAR Hedge Fund Activity: Q1 2014 in Review

1 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta Sugar ETN (SGAR) for Q1 2014, worth a combined $28K — up 211% from $9K a quarter earlier.

Fund positioning in SGAR was balanced in Q1 2014: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS, adding an estimated $17.8K.

  • 1 institutional investor held iPath Pure Beta Sugar ETN (SGAR) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $28K of iPath Pure Beta Sugar ETN stock for Q1 2014, up 211% quarter-over-quarter.
  • 0 funds opened new iPath Pure Beta Sugar ETN positions in Q1 2014 and 0 closed out.
  • The largest iPath Pure Beta Sugar ETN buyer in Q1 2014 was UBS, an estimated $17.8K added.

Based on aggregated 13F filings for Q1 2014.